Ceredex Value Advisors Reduces Stake in Vontier Corporation

Investment firm cuts holdings in automotive technology company by 16.9% in Q3

Published on Mar. 10, 2026

Ceredex Value Advisors LLC, an investment management firm, reduced its stake in Vontier Corporation (NYSE:VNT) by 16.9% in the third quarter of 2025, according to a recent SEC filing. Ceredex previously owned 850,650 shares of the automotive technology company, but sold 173,100 shares during the period, leaving it with a 0.59% ownership stake valued at $35.7 million.

Why it matters

Vontier is a spinoff of Fortive Corporation focused on mobility infrastructure and transportation solutions. As a relatively new public company, changes in institutional ownership can provide insight into how Wall Street views its growth prospects and competitive positioning.

The details

According to the SEC filing, Ceredex Value Advisors reduced its Vontier holdings from 850,650 shares to 677,550 shares in Q3 2025. This 16.9% reduction in the firm's stake came as Vontier's stock price fluctuated between $27.22 and $48.20 over the past year. Ceredex is one of Vontier's larger institutional investors, previously owning 0.59% of the company's outstanding shares.

  • Ceredex Value Advisors filed its Q3 2025 13F report with the SEC on March 10, 2026.
  • Vontier Corporation's stock price ranged from a 52-week low of $27.22 to a high of $48.20 over the past year.

The players

Ceredex Value Advisors LLC

An investment management firm that previously owned a 0.59% stake in Vontier Corporation.

Vontier Corporation

An American automotive technology company that was spun off from Fortive Corporation in 2020, focused on mobility infrastructure and transportation solutions.

Got photos? Submit your photos here. ›

The takeaway

Ceredex Value Advisors' reduction in its Vontier holdings suggests the investment firm may have a more cautious outlook on the automotive technology company's near-term growth prospects compared to its previous position. However, Vontier remains an important holding for Ceredex, underscoring the firm's belief in the company's long-term potential despite the recent stock price volatility.